Retatrutide is a synthetic research peptide that has generated significant interest in the metabolic research community. Its formal designation is LY3437943, and it was developed by Eli Lilly and Company. What makes retatrutide stand out is straightforward: it is designed to activate three different receptor types in a single molecule.
Access verified quality documentation and research-grade peptides.
View Certificates of Analysis Explore Research-Grade PeptidesDisclaimer: All compounds referenced in this article are intended for laboratory research use only. They are not approved for human or veterinary use by the FDA or any regulatory agency.